Share Twitter LinkedIn Facebook Email Aziz Nazha MD of Cleveland Clinic discusses using Personalized Prognoses for Myelodysplastic Syndromes Using Machine Learning at ASH 2018
Spotlight on Myelofibrosis 2024: The Critical Evolution of JAK Inhibitors Myeloproliferative Disease 3 Mins Read
